In hepatocellular cancer and pancreatic cancer, miR-181 and miR92a, respectively, negatively regulate the DUSP10 expression, affecting the proliferation and migration of tumorigenic cells [31,32]. Here, DUSP10 is linked to pancreatic neoplasm.